High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1

Man K S Lee1,2, Xiao-Lei Moore1, Yi Fu1

  • 1Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

Insights

High-density lipoproteins (HDL) inhibit the development of inflammatory M1 macrophages, a key factor in atherosclerosis. This effect is mediated by caveolin-1, impacting inflammatory signaling pathways.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Cell Biology

Background:

  • Macrophages play a crucial role in atherosclerosis development.
  • Macrophage functional phenotypes are influenced by their microenvironment.
  • High-density lipoproteins (HDL) possess significant anti-inflammatory and cardio-protective properties.

Purpose of the Study:

  • To investigate the impact of HDL on human macrophage phenotype.
  • To elucidate the underlying mechanisms of HDL's effects on macrophages.

Main Methods:

  • Human monocytes differentiated into macrophages.
  • Macrophages polarized to M1 (inflammatory) or M2 (anti-inflammatory) phenotypes.
  • HDL treatment and assessment of M1/M2 markers, inflammatory gene expression, ROS production, and signaling pathways (ERK1/2, STAT3).
  • Utilized caveolin-1 knockout mouse macrophages to confirm mechanism.

Main Results:

  • HDL significantly inhibited M1 macrophage induction, reducing M1 markers (CD192, CD64) and inflammatory genes (TNF-α, IL-6, MCP-1).
  • HDL suppressed M1 macrophage function by decreasing reactive oxygen species (ROS) production.
  • HDL's inhibitory effect on M1 polarization was dependent on caveolin-1 and involved decreased ERK1/2 and STAT3 phosphorylation.
  • HDL did not affect M2 macrophage polarization.

Conclusions:

  • HDL effectively reduces the induction of pro-atherosclerotic M1 macrophages.
  • The mechanism involves caveolin-1 redistribution, inhibiting ERK1/2 and STAT3 activation.
  • HDL's anti-inflammatory actions on macrophages offer potential therapeutic strategies for atherosclerosis.
Abstract